Wall Street analysts flagged looming headwinds ranging from the end of U.S. electric vehicle tax credits to continued profit margin pressures.
Jefferies downgrades Apple to sell, sees 20% drop from here
Apple shares are likely to slump as Wall Street’s expectations for the company’s next iPhone — possibly a foldable — have become too lofty, Jefferies says.
Here are Friday’s biggest analyst calls: Nvidia, Apple, Broadcom, Tesla, Netflix, Ferrari, Johnson & Johnson, Coinbase & more
Here are Friday’s biggest calls on Wall Street.
Johnson & Johnson is a buy as drug sales continue to improve, Wells Fargo says
The bank upgraded the pharma giant to overweight from equal weight.
Coinbase gets an upgrade from Rothschild on growing crypto adoption in finance
Coinbase is poised outperform as cryptocurrencies become more integrated into financial services, according to Rothschild & Co. Redburn.
Santoli’s Thursday market wrap-up: Stocks take the path of least resistance with no pesky data in its way
Mike Santoli’s notes on a market that continues to largely ignore the government shutdown.
Dan Ives says AI-related M&A ‘floodgates’ are about to open. Here are his takeover picks
Dan Ives flagged several companies poised to become acquisition targets as AI-related dealmaking starts to boom.
Best Buy is set for strong gains as momentum improves, according to the charts
David Keller walks through Best Buy’s technical outlook.
Disney’s image tanks among Republicans, Democrats after Jimmy Kimmel controversy
Sentiment and brand awareness for the company and its Disney+ platform have fallen to levels not seen in two years.
This Best Stock is the Salesforce of drug discovery. Time to get long here
Josh and Sean break down the reason behind the momentum of this unique healthcare stock.